Clene (CLNN) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLNN Clene Inc CLNN
34 GF Score
Price $4.20
GF Value $0.87
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clene Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

CLNN
34GF Score
Clene Inc CLNN
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (CLNN) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of $4.20 is trading 383.2% above its estimated GF Value™ of $0.87. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for CLNN:

  • Cash Payments:
  • GF Value™: $0.87 vs. price of $4.20 (383.2% above fair value)
  • GF Score™: 34/100 with 8 warning signs

No single metric tells the full story. See the CLNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clene Business Description

Other Exchanges 84C0:Germany
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
34GF Score

Get the complete analysis for CLNN

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.20
Price
$0.87
GF Value